Efficacy of S26308 against guinea pig cytomegalovirus infection.
Prophylactic use of antiviral agents against cytomegalovirus (CMV) is particularly indicated for the immunocompromised host because morbidity and mortality due to CMV occur most frequently following immunosuppression. We have evaluated the new Riker compound S26308 for its therapeutic and prophylact...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1988
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172251/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2840014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.5.678 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|